SCHEMBL1667962

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL12637962	0.91	CRACR2A (0.83)	CRACR2ANPC1RAB9AGMNNLMNA
	SCHEMBL1883639	0.86	CRACR2A (1.00)	CRACR2AORAI1NPC1RAB9AGMNN
	SCHEMBL1881601	0.82	CRACR2A (1.00)	CRACR2AORAI1NPC1RAB9ASMN1; SMN2
	SCHEMBL1668007	0.82	CRACR2A (0.76)	CRACR2AORAI1
	SCHEMBL1883281	0.81	CRACR2A (0.75)	CRACR2AORAI1
	SCHEMBL12637829	0.78	CRACR2A (0.68)	CRACR2AORAI1
	SCHEMBL1668375	0.78	CRACR2A (1.00)	CRACR2AORAI1
	SCHEMBL1667966	0.77	CRACR2A (0.81)	CRACR2AORAI1
	SCHEMBL12638066	0.77	CRACR2A (0.80)	CRACR2ANPC1RAB9AGMNNLMNA
	SCHEMBL12637818	0.76	CRACR2A (0.73)	CRACR2AORAI1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.